Zynex Medical Electrotherapy Pain Management and Growth Strategy

$6.0 $5.0 Adjusted Quarterly EBITDA ($ Millions) $4.0 $3.0 $2.0 $1.0 ($1.0) الس Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2- Est 2018 2019 2020 2021 Q1-2021 ($0.4M) (Q1 seasonality and continued investment in growing sales force) Q2-2021 Estimated Adjusted EBITDA $3.0M-$4.0M Note: Adjusted EBITDA reflects earnings before interest, taxes, depreciation, amortization, other income/expense and stock compensation. Depreciation does not include amounts related to units on lease to third parties which are depreciated and included in cost of goods sold See appendix for EBITDA reconciliation figures ZYNEX 18 MEDICAL"

View entire presentation